Abstract
Although the pathogenesis of hypertension in patients on maintenance haemodialysis is not completely understood, one of the important contributing factors is an increase in total peripheral vascular resistance (Kim et al. 1972). Page and McCubbin (1953) discovered the monoamine serotonin and suggested it may have a role in the regulation of blood pressure. However, its function in the regulation of blood pressure is still unclear. Clinical investigations of the serotonin S2-receptor antagonist ketanserin have shown that ketanserin reduces systemic vascular resistance and lowers blood pressure following acute or long term administration in patients with essential hypertension (De Cree et al. 1981; Fagard et al. 1984; Wenting et al. 1984). In this study, the acute effects of ketanserin on blood pressure and hormonal responses in 10 patients on maintenance haemodialysis with hypertension were determined in order to assess the role of endogenous serotonin in the regulation of blood pressure in such patients. The long term effect of ketanserin on pressor responsiveness to the £x,-adrenoreceptor agonist phenylephrine was also determined in 5 patients. 1. Methods
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
